Polycystic ovary syndrome - Metformin treatment in pregnancy

dc.contributor.author	Vanky, Eszter	nb_NO
dc.date.accessioned	2014-12-19T14:16:45Z
dc.date.available	2014-12-19T14:16:45Z
dc.date.created	2006-02-15	nb_NO
dc.date.issued	2005	nb_NO
dc.identifier	125840	nb_NO
dc.identifier.isbn	82-471-7282-8	nb_NO
dc.identifier.uri	http://hdl.handle.net/11250/263145
dc.language	eng	nb_NO
dc.publisher	Det medisinske fakultet	nb_NO
dc.relation.ispartofseries	Doktoravhandlinger ved NTNU, 1503-8181; 2005:194	nb_NO
dc.relation.haspart	Vanky, E; Kjøtrød, S; Salvesen, KÅ; Romundstad, P; Moen, MH; Carlsen, SM. Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS. Acta Obstetricia et Gynecologica Scandinavica. 83(3): 482, 2004.	nb_NO
dc.relation.haspart	Vanky, E; Salvesen, KÅ; Heimstad, R; Fougner, KJ; Romundstad, P; Carlsen, SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women. Human Reproduction. 19(8): 1734-1740, 2004.	nb_NO
dc.relation.haspart	Vanky, E; Zahlsen, K; Spigset, O; Carlsen, SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertility and Sterility. 83(5): 1575-1578, 2005.	nb_NO
dc.subject	Polycystic Ovary Syndrome	en_GB
dc.subject	Pregnancy	en_GB
dc.subject	MEDICINE	en_GB
dc.title	Polycystic ovary syndrome - Metformin treatment in pregnancy	nb_NO
dc.type	Doctoral thesis	nb_NO
dc.contributor.department	Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet	nb_NO
dc.description.degree	dr.med.	nb_NO
dc.description.degree	dr.med.	en_GB